Interpace Diagnostics Group Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
4,565.00
16,073.00
11,356.00
8,332.00
12,216.00
12,189
Depreciation, Depletion & Amortization
1,425.00
2,391.00
5,030.00
4,270.00
3,690.00
3,464
Other Funds
-
20,000.00
20,000.00
475.00
25.00
3,885
Funds from Operations
2,485.00
12,320.00
8,323.00
9,040.00
7,921.00
4,840
Changes in Working Capital
1,027.00
4,058.00
6,531.00
1,433.00
7,342.00
3,833
Net Operating Cash Flow
3,512.00
16,378.00
19,842.00
7,607.00
15,263.00
8,673
Capital Expenditures
1,818.00
11,351.00
353.00
-
29.00
Sale of Fixed Assets & Businesses
-
-
26,751.00
-
-
Purchase/Sale of Investments
1,500.00
-
-
-
-
Net Investing Cash Flow
3,318.00
25,365.00
26,398.00
-
29.00
Issuance/Reduction of Debt, Net
-
557.00
1,600.00
1,333.00
-
Net Financing Cash Flow
314.00
19,215.00
21,357.00
101.00
29,889.00
Net Change in Cash
7,144.00
22,528.00
14,801.00
7,708.00
14,597.00
Free Cash Flow
5,330.00
19,229.00
20,195.00
7,607.00
15,292.00
Deferred Taxes & Investment Tax Credit
-
5,035.00
1,167.00
-
-
-
Net Assets from Acquisitions
-
13,359.00
-
-
-
Change in Capital Stock
314.00
228.00
243.00
1,707.00
29,914.00
Other Uses
-
655.00
-
-
-
Extraordinaries
-
-
21,634.00
-
-
-
About Interpace Diagnostics Group
View Profile
